Urinary System

Urinary Bladder - Dilation

Narrative
Comment:
Dilation of the urinary bladder is characterized by an overly distended bladder with flattened urothelium (Figure 1). This is a commonly observed change, which can result from a number of etiologies. The most common cause is obstruction. Cases of urinary bladder dilation may be noted where the cause is not apparent or related to chemical administration. The etiology of bladder dilation may be missed when the urethra is not examined. Mouse urologic syndrome in male animals is a frequent cause of obstruction, bladder dilation, inflammation, morbidity, and death. Calculi may also block the outflow of urine, leading to dilation. Although proteinaceous plugs may be observed in the trigone region of the urinary bladder, these plugs usually do not contribute to dilation because in most cases they represent agonal events. Formalin inflation of the urinary bladder is usually recommended, but overinflation and other inflation-related artifacts may occur.
Recommendations:
Dilation of the urinary bladder should be diagnosed and given a severity grade. Identification of cause should be considered if dilation is treatment related. If the cause can be identified, it should be diagnosed separately and its relationship to the urinary bladder dilation discussed in the narrative.
References:

Babcock VI, Southam CM. 1965. Obstructive uropathy in laboratory mice. Proc Soc Exp Biol Med 120:580-581.

Abstract: http://ebm.sagepub.com/content/120/2/580.abstract

Collins GR, Goodheart CR, Henson D. 1972. Spontaneous heritable hydronephrosis in inbred mice. 1. Description, incidence, and distribution of lesions. Lab Anim Sci 22:333-338.

Abstract: http://www.ncbi.nlm.nih.gov/pubmed/4338696

Everitt JI, Ross PW, Davis TW. 1988. Urologic syndrome associated with wire caging in AKR mice. Lab Anim Sci 38:609-611. PMID: 3193755.

Frazier KS, Seely JC, Hard GC, Betton G, Burnett R, Nakatsuji S, Nishikawa A, Durchfeld-Meyer B, Bube A. 2012. Proliferative and non-proliferative lesions in the rat and mouse urinary system. Toxicol Pathol 40:14S-86S.

Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22637735

Hsu HH. 1986. Hereditary hydronephrosis, mouse. In: Monographs on Pathology of Laboratory Animals: Urinary System (Jones TC, Hard GC, Mohr U, eds). Springer, Berlin, 273-275.

Abstract: http://www.ilsi.org/publications/urinarysystem.pdf

Maronpot RR. 1998. Spontaneous hydronephrosis, rat. In: Monographs on Pathology of Laboratory Animals: Urinary System, 2nd ed (Jones TC, Hard GC, Mohr U, eds). Springer, Berlin, 306-309.

Abstract: http://www.ilsi.org/publications/urinarysystem.pdf

Sokoloff L, Barile MF. 1962. Obstructive genitourinary disease in male STR/1N mice. Am J Pathol 41:233-246.

Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949600/

Weide LG, Lacy PE. 1991. Hereditary hydronephrosis in C57BL/KsJ mice. Lab Anim Sci 41:415-418.

Abstract: http://www.ncbi.nlm.nih.gov/pubmed/1666139
  • Image of dilation in the urinary bladder from a male B6C3F1 mouse in a chronic study

    Dilation of the urinary bladder with focal to diffuse flattening of urothelium, from a male B6C3F1 mouse in a chronic study.

Enlarge Image
Enlarge All Images
<p>Dilation of the urinary bladder with focal to diffuse flattening of urothelium, from a male B6C3F1 mouse in a chronic study.</p>

Dilation of the urinary bladder with focal to diffuse flattening of urothelium, from a male B6C3F1 mouse in a chronic study.
<p>Normal bladder for comparison, from a male B6C3F1 mouse in a subchronic study.</p>

Normal bladder for comparison, from a male B6C3F1 mouse in a subchronic study.

Authors

John Curtis Seely, DVM, DACVP
Senior Pathologist
Experimental Pathology Laboratories, Inc.
Research Triangle Park, NC

Abraham Nyska,  DVM, Diplomate ECVP, Fellow IATP
Expert in Toxicologic Pathology
Visiting Full Professor of Pathology
Sackler School of Medicine, Tel Aviv University
Timrat Israel

Reviewers

Samuel M Cohen, PHD, MD
Professor
Havlik-Wall Professor of Oncology
Director of Pathology Residency Program
Nebraska Medical Center
Omaha, NE

David E. Malarkey DVM, PhD, DACVP, FIATP
Head, National Toxicology Program Pathology Group
Cellular and Molecular Pathology Branch
Division of the National Toxicology Program
National Institute of Environmental Health Sciences
Research Triangle Park, NC